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Abstract: Ricinus communis intoxications have been known for centuries and were attributed to
the toxic protein ricin. Due to its toxicity, availability, ease of preparation, and the lack of medical
countermeasures, ricin attracted interest as a potential biological warfare agent. While different
technologies for ricin analysis have been established, hardly any universally agreed-upon “gold
standards” are available. Expert laboratories currently use differently purified in-house materials,
making any comparison of accuracy and sensitivity of different methods nearly impossible.
Technically challenging is the discrimination of ricin from R. communis agglutinin (RCA120), a less
toxic but highly homologous protein also contained in R. communis. Here, we established both
highly pure ricin and RCA120 reference materials which were extensively characterized by gel
electrophoresis, liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI
MS/MS), and matrix-assisted laser desorption ionization–time of flight approaches as well as
immunological and functional techniques. Purity reached >97% for ricin and >99% for RCA120.
Different isoforms of ricin and RCA120 were identified unambiguously and distinguished by LC-ESI
MS/MS. In terms of function, a real-time cytotoxicity assay showed that ricin is approximately
300-fold more toxic than RCA120. The highly pure ricin and RCA120 reference materials were used
to conduct an international proficiency test.
Keywords: proficiency test; ricin; reference material
1. Introduction
Originally identified by Stillmark in 1888 [1], ricin is produced by Ricinus (R.) communis
and is one of the most toxic plant toxins known today. It belongs to the family of type II
ribosome-inactivating proteins [2]. As a prototype AB toxin, ricin consists of a sugar-binding B chain
(~34 kDa) linked via a disulfide bond to the catalytically active A chain (~32 kDa) which acts as
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an RNA N-glycosidase, resulting in a holotoxin of about 65 kDa [3,4]. As lectin, the B chain mediates
cell binding via different oligosaccharide residues on the cell surface, including N-acetylglucosamine
and galactose residues found on glycolipids and glycoproteins [5–7]. Previously, oligosaccharides
have been employed for the purification of ricin by affinity chromatography [8–10]. After
internalization, the A-B heterodimer undergoes retrograde transport via the Golgi network
to the endoplasmic reticulum where the heterodimer is reduced and separated into the two
subchains [11,12]. The A chain is then transported into the cytosol and binds to the ribosome where it
removes a single adenine from the 28S rRNA, thus preventing further binding of elongation factors,
inhibiting protein biosynthesis, and finally leading to cell death [13–15].
The understanding of ricin is complicated by the fact that, besides ricin, R. communis seeds
contain the homologous but less toxic protein R. communis agglutinin, abbreviated RCA120 [6].
RCA120 is a 120 kDa heterotetrameric protein consisting of two ricin-like heterodimers linked via
a disulfide bond between the two A chains [16]. Different isoforms of ricin have been described,
adding further complexity to the issue: the original isoform now termed ricin D is accompanied in
most R. communis cultivars by the isoform ricin E which contains a hybrid B chain composed of the
N-terminal part of the original ricin B chain and the C-terminal part of the RCA120 B chain ([17–19]).
Ricin and RCA120 show a high sequence homology of 93% and 84% between the A and B chains
of ricin and RCA120, respectively [20]. Still, ricin is a potent toxin but a weak hemagglutinin, whereas
RCA120 is only a weak toxin but a strong hemagglutinin [21,22]. Depending on the experimental
system used, the difference in toxicity between ricin and RCA120 was described to be about
60–2000 times [8,22–24]. Accidental and intended R. communis intoxications in humans and animals
have been known for centuries. The toxicity of ricin in vivo is estimated to be 1–20 mg/kg body weight
when ingested and 1–10 µg/kg body weight when delivered by inhalation or injection [4].
Both ricin and RCA120 are not single copy genes, but rather part of a larger ricin gene
family encoding for seven full-length ricin or ricin-like proteins and several potential shorter gene
products of unknown expression and function, indicating a greater variability than previously
anticipated [4,25,26]. The seven full-length proteins of the ricin gene family have been found to
inhibit protein synthesis similar to ricin itself [4,26]. Ricin contains four glycosylation sites, two on
the A chain and two on the B chain [4,27], and additional heterogeneity of the molecule is based on
different glycosylation patterns: it has been shown that variable toxicities of ricin isoforms have been
correlated with different glycosylation levels [28,29]. Another level of complexity has recently been
added by the description of heterogeneity in the deamidation pattern, the conversion rate of single
asparagine residues to aspartic and isoaspartic acid [30].
Ricin and the ricin-producing plant are typical dual-use substances: R. communis is grown
worldwide on an industrial scale as a source of castor oil which is—because of the high content of
the unsaturated fatty acid ricinoleic acid and its favorable physico-chemical properties—a valued
raw material for the production of lubricants, pharmaceuticals, cosmetics, paints, coatings, inks,
and many other products. During the extraction process ricin accrues as a by-product of the oil’s
production [31]. Its high toxicity, availability, and the relative ease of extraction make ricin a potential
agent for bioterrorism [32]. Consequently, ricin is listed as a category B agent of potential bioterrorism
risk by the Centers for Disease Control and Prevention (CDC) [33]. Actually, ricin has been used
for small-scale attacks such as the assassination of Georgi Markov [34,35]. High media coverage
was gained by the ricin-containing threat letters sent in 2003 and 2013 to members of the U.S.
Senate and the White House as well as to U.S. President Obama [36,37]. Additionally, ricin has
a history of military use by different nations and was included in different weapons programs during
World War II and later [36,38–40]. Therefore, ricin is a prohibited substance both under the Chemical
Weapons Convention (CWC, schedule 1 compound) and the Biological Weapons Convention (BWC);
its possession and production must be declared to the Organisation for the Prohibition of Chemical
Weapons (OPCW), and it may be used only for strictly specified purposes defined in the CWC.
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Against the background of the toxin’s potential misuse for terrorist, criminal, or military
purposes, the rapid, sensitive, and ideally unambiguous detection of ricin is necessary.
While different technologies for ricin detection and identification have been established using
immunological, spectrometric, functional, or molecular approaches, hardly any universally
agreed-upon “gold standards” are available [4]. No certified reference material is available, and
expert laboratories currently use differently purified in-house materials as a standard, making any
comparison of accuracy and sensitivity of different methods nearly impossible. Also there are open
questions as to which methods have to be used and combined to obtain preliminary, confirmed,
and unambiguous results. Depending on the task and scenario, the discrimination of ricin from
the homologous RCA120 is important, as only ricin is recognized as a threat agent under the BWC
and a schedule 1 component under the CWC. In the context of a forensic analysis it might be
important to present information on purity and amount, biological activity, and potential source of
a suspect sample.
In this work, we have established both highly pure ricin and RCA120 reference materials
which were extensively characterized by biochemical, spectrometric, immunological, and functional
techniques. Especially liquid chromatography-electrospray ionization-tandem mass spectrometry
(LC-ESI MS/MS) was instrumental in differentiating the related ricin D, ricin E, and RCA120 from
each other. Both materials were later used in the framework of the European Union (EU) project
EQuATox (Establishment of quality assurance for the detection of biological toxins of potential
bioterrorism risk [41]) funded under the European Community’s Seventh Framework Programme
to organize and conduct a large international proficiency test (PT, [42]).
2. Results and Discussion
Depending on the primary protein sequence and its specific glycosylation and deamidation level,
ricin is a heterogeneous molecule with variable molecular weight, protein charge/isoelectric point,
and toxicity [27–30]. Against this background, an important question is from which cultivar or plant
variety ricin and the highly homologous RCA120 should be purified to generate well-characterized
reference materials since any characteristic might be attributed to that particular toxin isolated from
a selected cultivar and might not automatically be applied to toxins from other sources [27,30].
Commercially available ricin and RCA120 were purified from an unknown cultivar and also show
variable purities: 96% purity for ricin was reported, but only 68% purity for RCA120 [43]. The
question was discussed in the expert forum of the EQuATox consortium representing scientists from
35 laboratories and 20 countries internationally. Specifically, it was discussed whether the cultivar
R. communis zanzibariensis should be used as toxin source which has been shown to contain ricin D
only [44] or whether a cultivar like R. communis carmencita should be used which is known to contain
both ricin D and ricin E isolectins. Ricin from R. communis zanzibariensis can be clearly differentiated
from ricin purified from a panel of other cultivars and seems to be particular [27]. Therefore, it was
decided to use a more representative cultivar as source of toxin, even if this meant to purify a mixture
of ricin isolectins, namely D and E.
To this end, ricin and RCA120 were prepared from the seeds of R. communis carmencita
following previously published procedures [8,45,46]. Both protein preparations were thoroughly
characterized, combining technically independent and complementary approaches to describe the
purity, composition, and activity of both ricin and RCA120 using biochemical, spectrometric,
immunological, and functional methods (Figure 1).
At the beginning of the study, a highly precise and accurate quantification of both purified
protein preparations was important for the subsequent comparison of quantitative results reported
in the proficiency test. It is known that different protein quantification methods such as
Bradford assay [47], Lowry method [48], or amino acid analysis based on isotope dilution mass
spectrometry [49] deliver variable results depending on the size and charge of the target protein,
its amino acid composition, glycosylation pattern or other post-translational modifications, buffer
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conditions and potential impurities present in a protein sample [50,51]. Based on the facts that both
protein preparations were determined to be highly pure glycoproteins (see Sections 2.1 and 2.2) and
to have available well-established extinction coefficients for ricin and RCA120, it was decided to use
the measurement of absorbance at 280 nm for quantification of the protein content. Based on the
absorption measured at 280 nm and according to Lambert-Beer’s law and the known extinction
coefficients ε = 1.1615 mL ˆ mg´1 ˆ cm´1 for ricin [52] and ε = 1.17 mL ˆ mg´1 ˆ cm´1 for
RCA120 [6], the protein concentrations were determined at c(ricin) = 1.51 ˘ 0.043 mg/mL and
c(RCA120) = 1.03 ˘ 0.035 mg/mL.
Figure 1. Schematic overview of technical approaches used to describe the purity, composition, and
activity of highly purified ricin and RCA120 from R. communis carmencita.
2.1. Size, Purity and Composition
2.1.1. Composition and Purity by Gel Electrophoresis
In order to display an overview of the composition and purity of the ricin and RCA120
preparations, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and capillary
gel electrophoresis (CGE) were performed as a first step. As displayed in Figure 2, both ricin
and RCA120 preparations showed distinct, sharp bands upon separation in an SDS-PAGE and no
degradation of proteins was observed. Non-reduced ricin was running at about 60 kDa, while
non-reduced RCA120 was arbitrarily running at a higher molecular weight between 120 kDa and
170 kDa. This behavior has been observed before for other preparations of RCA120 [6]. Under
reducing conditions, ricin migrated in two bands of around 33 and 35 kDa, where the lower band
has been shown to contain the ricin A chain and the upper band a higher glycosylated form of the
ricin A chain plus the ricin B chain [51]. RCA120 was showing three bands of about 33–36 kDa, and
the result was in good accord with previously reported data [6,28,29,51].
For both protein preparations, a number of faint bands of lower molecular weight than the
full-length toxins were observed by SDS-PAGE. These bands could potentially represent shorter
fragments of ricin or RCA120, respectively, or completely unrelated proteins co-purified from
R. communis. The identity of these trace contaminants was clarified by matrix-assisted laser
desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis (see Section 2.2.2).
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Figure 2. Protein separation of purified ricin and RCA120 from R. communis carmencita. 
10% SDS-PAGE of either purified ricin (3 µg of ricin each) or purified RCA120 (5 µg of 
RCA120 each) separated under non-reducing conditions (left panel) or under reducing 
conditions (right panel, use of β-mercaptoethanol as reducing agent) followed by staining 
with Coomassie Brilliant Blue. 
As judged from the main protein bands, no significant cross-contamination of ricin with RCA120 or, 
vice versa, RCA120 with ricin was observed, and the purity was estimated to be >95%. Since this point 
was important for designing proper PT samples, it was further analyzed using CGE. 
 
Figure 3. CGE analysis of a crude R. communis extract containing seed storage protein  
(SSP, 13 kDa), ricin (65 and 70 kDa), and RCA120 (146 kDa). Prior to analysis, the 
molecular weight markers at 1.2 kDa and 260 kDa were added for calibration. 
Figure 3 shows a CGE electropherogram of a crude extract of R. communis containing R. communis 
seed storage protein (SSP), ricin, and RCA120. The molecular weight of the analytes was evaluated by 
the instrument software using a series of molecular weight standards analyzed in each chip and the 
molecular weight markers present in the sample buffer. Electropherograms of the purified ricin 
preparation and the purified RCA120 preparation are shown in Figure 4. In the ricin preparation the peak 
doublet at 65–70 kDa was attributed to ricin. No peak from RCA120—expected at 146 kDa and a 
running time of around 40 s—was observed (Figure 4a,b). To evaluate and confirm the CGE results, 
standard addition experiments were conducted. An amount of RCA120 corresponding to 5% of the 
concentration of ricin was added to the purified ricin preparation. In Figure 4c, a peak near the detection 
Figure 2. Protein separation of purified ricin and RCA120 from R. communis carmencita. 10%
SDS-PAGE of either purified ricin (3 µg of ricin each) or purified RCA120 (5 µg of RCA120 each)
separated under non-reducing conditions (left panel) or under reducing condit ons (right panel, use
of β-mercaptoethanol as reducing agent) followed by staining with Coomassie Brilliant Blue.
As judged from the main protein bands, no significant cross-contamination of ricin with RCA120
or, vice versa, RCA120 with ricin was observed, and the purity was estimated to be >95%. Since this
point was important for designing proper PT samples, it was further analyzed using CGE.
Figure 3 shows a CGE electropherogram of a crude extract of R. communis containing R. communis
seed storage protein (SSP), ricin, and RCA120. The molecular weight of the analytes was evaluated
by the instrument software using a series of molecular weight standards analyzed in each chip and
the molecular weight markers present in the sample buffer. Electropherograms of the purified ricin
preparation and the purified RCA120 preparation are shown in Figure 4. In the ricin preparation
the peak doublet at 65–70 kDa was attributed to ricin. No peak from RCA120—expected at 146 kDa
and a running time of around 40 s—was observed (Figure 4a,b). To evaluate and confirm the CGE
results, standard addition experiments were conducted. An amount of RCA120 corresponding to 5%
of the concentration of ricin was added to the purified ricin preparation. In Figure 4c, a peak near the
detection limit was observed (marked with a green arrow), which indicates that the RCA120 content
in the purified ricin sample was less than 5%.
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Figure 3. CGE analysis of a crude R. communis extract containing seed storage protein (SSP, 13 kDa),
ricin (65 and 70 kDa), and RCA120 (146 kDa). Prior to analysis, the molecular weight markers at
1.2 kDa and 260 kDa were added for calibration.
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ricin sample was less than 5%.  
 
Figure 4. CGE analysis. Electropherogram of purified ricin (a–c) and purified RCA120  
(d–f). For (a), the ricin preparation was diluted 1:1 and a ricin doublet peak at approximately 
33 s was obtained; (b) expanded region around 40 s migration time where a signal of 
RCA120 would be expected (black arrow); (c) standard addition of 5% of RCA120 to the 
ricin preparation (0.076 mg of RCA120/mL), highlighted by a green arrow. For (d), the 
RCA120 preparation diluted 1:1 resulted in a broad peak indicating RCA120 at 
approximately 40 s; (e) expanded electropherogram of (d) indicating a small peak at the 
migration time of ricin at 34 s (black arrow). The integrated peak area was equivalent to 
1.8% relative to the RCA120 peak area. (f) Standard addition of 2% of ricin to the RCA120 
preparation (0.02 mg of ricin/mL).  
In the RCA120 preparation, a peak from RCA120 was obtained at 120–150 kDa and a minor peak at 
the migration time of ricin of around 33 s could be observed (black arrow). The concentration of ricin 
relative to the RCA120 in this preparation was estimated by the software to be 1.8% (Figure 4d,e).  
Figure 4. CGE analysis. Electropherogram of purified ricin (a–c) and purified RCA120 (d–f). For (a),
the ricin preparation was diluted 1:1 and a ricin doublet peak at approximately 33 s was obtained;
(b) expanded region around 40 s migration time where a signal of RCA120 would be expected (black
arrow); (c) standard addition of 5% of RCA120 to the ricin preparation (0.076 mg of RCA120/mL),
highlighted by a gr en arrow. For (d), the RCA120 prepar tion iluted 1:1 resulted in a broad peak
indicating RCA120 at approximately 40 s; (e) expanded electropherogram of (d) indicating a small
peak at the migration time of ricin at 34 s (black arrow). The integrated peak area was equivalent to
1.8% relative to the RCA120 peak area. (f) Standard addition of 2% of ricin to the RCA120 preparation
(0.02 mg of ricin/mL).
In the RCA120 preparation, a ea from RCA120 was obtained at 120–150 kDa and a minor peak
at the migration time of ricin of around 33 s could be observed (black arrow). The concentration of
ricin relative to the RCA120 in this preparation was estimated by the software to be 1.8% (Figure 4d,e).
The result was confirmed by the addition of 2% of ricin relative to the RCA120 concentration. The
peak attributed to ricin increased in size by a factor of approximately two (Figure 4f, green arrow).
2.1.2. Molecular Weight by LC-ESI MS
The molecular weight of the purified, intact ricin preparation was determined based on LC-ESI
MS. The molecular weight was both calculated manually from the data as well as determined from
deconvoluted mass spectra. The spectra obtained showed the heterogeneity in ricin due to a varying
level of glycosylation (Figure 5). Based on previous experiments and literature data, the glycosylation
pattern of the mass spectrum is indicative of the cultivar used for the isolation of ricin [27].
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Figure 6. Deconvoluted mass spectrum of purified ricin preparation. 
Adjacent peaks in the deconvoluted mass spectrum of the purified ricin in Figure 6 are separated by 
162 mass units which correspond to different ricin glycoforms separated by the number of hexose units 
in the attached glycan structures. The molecular weight determined by the instrument software for the 
major glycoform was 63,034 Da. The manually calculated molecular weight using the peaks in the range 
indicated in Figure 5 was determined at 63,032 ± 2 Da. This matches well the molecular weight of 
previously prepared ricin from the same cultivar (unpublished) and published information [27,53–55]. 
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Figure 5. LC-ESI MS spectrum of purified ricin preparation. The highlighted range 1000–1280 m/z
indicated by a green arrow was used for manual molecular weight determination.
Adjacent peaks in the deconvoluted mass spectrum of the purified ricin in Figure 6 are separated
by 162 mass units which correspond to different ricin glycoforms separated by the number of
hexose units in the attached glycan structures. The molecular weight determined by the instrument
software for the major glycoform was 63,034 Da. The manually calculated molecular weight using
the peaks in the range indicated in Figure 5 was determined at 63,032 ˘ 2 Da. This matches well the
molecular weight of previously prepared ricin from the same cultivar (unpublished) and published
information [27,53–55].
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Figure 6. Deconvoluted mass spectrum of purified ricin preparation.
2.2. Identification of Ricin and RCA120 and Analysis of Potential Trace Contaminants
2.2.1. Identification f Ricin and RCA120 by Tryptic Fingerprinting and Sequencing
The aim of the LC-ESI MS/MS analysis (this section) and the MALDI-TOF MS/MS analysis
(Section 2.2.2) was to unambiguously identif ricin and RCA120 in the protein preparations prepared
from R. communis and to thoroughly check for potential cross-contaminations with other R. communis
proteins. To this end, both preparations were reduced, alkylated, and underwent tryptic digestion.
The tryptic fragments were analyzed and sequenced by LC-ESI MS/MS, focusing on identification
of the isoforms of ricin D, ricin E, and their corresponding A and B chains, as well as RCA120.
Figure 7 exemplarily shows the base peak chromatograms of the trypsin digests of ricin and RCA120
preparations obtained by LC-ESI MS/MS analysis. The peptides from ricin D observed in the ricin
preparation covered 95% of the sequence of the A chain and 74% of the B chain. In the RCA120
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preparation, peptides representing 90% of the A chain and 79% of the B chain of RCA120 were
detected. The full sequences of ricin D, ricin E, and RCA120 are displayed in Table 1. Sequences
displayed in red show peptides which were experimentally detected by combining LC-ESI MS/MS
and MALDI-TOF MS/MS data (this Section and Section 2.2.2).
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RCA120 re isplayed in Table 1. Sequenc s dis layed in red show peptides which were experimentally 
detected by combining LC-E I MS/MS and MALDI-TOF MS/MS data (this Section and Section 2.2.2). 
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(b) 
Figure 7. Base peak chromatograms of the trypsin digests of (a) purified ricin and (b) 
purified RCA120. The relative intensity is plotted against the retention time. Peaks are 
labeled with retention time and the m/z value of the base peak. 
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Figure 7. Base peak chromatograms of the trypsin digests of (a) purified ricin and (b) purified
RCA120. The relative intensity is plotted against the retention time. Peaks are labeled with retention
time and the m/z value of the base peak.
Tables 2 and 3 list the theoretical trypsin digest peptides obtained from chains A and B of ricin D
(Uniprot [56] ID: P02879), and those from chain B of ricin E (NCBI Genpept [57] ID: GI:225419 ) are
found in Table 4.
The corresponding trypsin digest peptides from RCA120 (Uniprot [56] ID: P06750) and for chain
B (NCBI Genpept [57] ID: GI:225114) are shown in Tables 5 and 6. In each of the tables, the molecular
ions of the experimentally observed peptides are indicated by bold typeface. Also, the peptides that
can be used to distinguish ricin D from ricin E and RCA120 from ricin D are indicated in bold typeface.
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Table 1. The amino acid sequences of ricin D, ricin E, and RCA120 identified in
purified ricin and purified RCA120. The experimentally detected sequences using liquid
chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI MS/MS) and
matrix-assisted laser desorption/ionization-time of flight tandem mass spectrometry (MALDI-TOF
MS/MS) as trypsin digest peptides are indicated in red.
Sequence coverage of ricin preparation:
Ricin D chain A (Uniprot P02879, NCBI GI:132567)
1 IFPKQYPIIN FTTAGATVQS YTNFIRAVRG RLTTGADVRH EIPVLPNRVG LPINQRFILV
61 ELSNHAELSV TLALDVTNAY VVGYRAGNSA YFFHPDNQED AEAITHLFTD VQNRYTFAFG
121 GNYDRLEQLA GNLRENIELG NGPLEEAISA LYYYSTGGTQ LPTLARSFII CIQMISEAAR
181 FQYIEGEMRT RIRYNRRSAP DPSVITLENS WGRLSTAIQE SNQGAFASPI QLQRRNGSKF
241 SVYDVSILIP IIALMVYRCA PPPSSQF
Ricin D chain B (Uniprot P02879, NCBI GI:132567)
1 ADVCMDPEPI VRIVGRNGLC VDVRDGRFHN GNAIQLWPCK SNTDANQLWT LKRDNTIRSN
61 GKCLTTYGYS PGVYVMIYDC NTAATDATRW QIWDNGTIIN PRSSLVLAAT SGNSGTTLTV
121 QTNIYAVSQG WLPTNNTQPF VTTIVGLYGL CLQANSGQVW IEDCSSEKAE QQWALYADGS
181 IRPQQNRDNC LTSDSNIRET VVKILSCGP ASSGQRWMFKN DGTILNLYSG LVLDVRASDP
241 SLKQIILYPL HGDPNQIWLP LF
Ricin E chain B (NCBI GI:225419)
1 ADVCMDPEPI VRIVGRNGLC VDVRDGRFHN GNAIQLWPCK SNTDANQLWT LKRDNTIRSN
61 GKCLTTYGYP SGVYVMIYDC NTAATDATRW QIWDNGTIIN PRSSLVLAAT SGNSGTTLTV
121 QTNIYAVSQG WLPTNNTQPF VTTIVGLYGM CLQANSGKVW LEDCTSEKAE QQWALYADGS
181 IRPQQNRDNC LTTDANIKGT VVKILSCGPA SSGQRWMFKN DGTILNLYNG LVLDVRRSDP
241 SLKQIIVHPV HGNLNQIWLP LF
Sequence coverage of RCA120 preparation:
RCA120 chain A (Uniprot P06750, NCBI GI:113504)
1 IFPKQYPIIN FTTADATVES YTNFIRAVRS HLTTGADVRH EIPVLPNRVG LPISQRFILV
61 ELSNHAELSV TLALDVTNAY VVGCRAGNSA YFFHPDNQED AEAITHLFTD VQNSFTFAFG
121 GNYDRLEQLG GLRENIELGT GPLEDAISAL YYYSTCGTQI PTLARSFMVC IQMISEAARF
181 QYIEGEMRTR IRYNRRSAPD PSVITLENSW GRLSTAIQES NQGAFASPIQ LQRRNGSKFN
241 VYDVSILIPI IALMVYRCAP PPSSQF
RCA120 chain B (NCBI GI:225114)
1 ADVCMDPEPI VRIVGRNGLC VDVFGEEFTD GNPIQLWPCK SNTDWNQLWT LRKDSTIRSD
61 GKCLTISKSS PGQQVVIYNC STATVGATRW QIWDNRTIIN PTSGLVLAAT SGNSGTKLTV
121 QTNIYAVSQG WLPTNNTQPF VTTIVGLYGM CLQANSGKVW LEDCTSEKAE QQWALYADGS
181 IRPQQNRDNC LTTDANIKGT VVKILSCGPA SSGQRWMFKN DGTILNLYNG LVLDVRRSDP
241 SLKQIIVHPV HGNLNQIWLP LF
Table 2. Ricin D and E chain A trypsin digest peptides (Uniprot [56] ID: P02879, NCBI Genpept [57] ID:
GI:132567), reduced and carbamidomethylated. Ricin/RCA120-distinguishing peptides and observed
molecular ions are given in bold.
T# (a) Amino Acid Sequence (M+H)+ (M+2H)2+ (M+3H)3+ (M+4H)4+
T1a IFPK 504.3180 - - -
T2a-glyc QYPIINFTTAGATVQSYTNFIR 3675.6946 * 1838.3509 * 1225.9031 * 919.6791 *
T3a AVR 345.2245 - - -
T4a GR 232.1404 - - -
T5a LTTGADVR 832.4523 416.7298 - -
T6a HEIPVLPNR 1074.6054 537.8063 - -
T7a VGLPINQR 896.5312 448.7692 - -
T8a FILVELSNHAELSVTLALDVTNAYVVGYR 3206.7095 1603.8584 1069.5747 802.4328
T9a AGNSAYFFHPDNQEDAEAITHLFTDVQNR 3307.5038 1654.2555 1103.1728 827.6314
T10a YTFAFGGNYDR 1310.5800 655.7936 - -
T11a LEQLAGNLR 1013.5738 507.2905 - -
T12a ENIELGNGPLEEAISALYYYSTGGTQLPTLAR 3440.7219 1720.8646 1147.5788 860.9359
T13a SFIICIQMISEAAR 1638.8342 819.9207 - -
T14a FQYIEGEMR 1172.5404 586.7738 - -
T15a TR 276.1666 - - -
T16a IR 288.2030 - - -
T17a YNR 452.2252 - - -
T18a R 175.1189 - - -
T19a SAPDPSVITLENSWGR 1728.8551 864.9312 - -
T20a LSTAIQESNQGAFASPIQLQR 2259.1727 1130.0900 753.7291 -
T21a R 175.1189 - - -
T22a NGSK 405.2092 - - -
T23a FSVYDVSILIPIIALMVYR 2212.2450 1106.6261 738.0865 -
T24a CAPPPSSQF 990.4349 495.7211 - -
(a) Trypsin digest peptides numbered from the amino terminal of the polypeptide chain. * Main glycopeptide.
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Table 3. Ricin D chain B trypsin digest peptides (Uniprot [56] ID: P02879, NCBI Genpept [57] ID:
GI:132567), reduced and carbamidomethylated. Ricin/RCA120 distinguishing peptides and observed
molecular ions are given in bold.
T# (a) Amino Acid Sequence (M+H)+ (M+2H)2+ (M+3H)3+ (M+4H)4+
T1b ADVCMDPEPIVR 1401.6501 701.3287 - -
T2b IVGR 444.2929 - - -
T3b NGLCVDVR 932.4618 466.7345 - -
T4b DGR 347.1673 - - -
T5b FHNGNAIQLWPCK 1584.7740 792.8906 - -
T6b SNTDANQLWTLK 1390.6961 695.8517 - -
T7b R 175.1189 - - -
T8b DNTIR 618.3205 - - -
T9b SNGK 405.2092 - - -
T10b CLTTYGYSPGVYVMIYDCNTAATDATR 3063.3532 1532.1802 1021.7893 766.5938
T11b-glyc WQIWDNGTIINPR 2991.2987 * 1496.1530 * 997.7711 * 748.5801 *
T12b-glyc SSLVLAATSGNSGTTLTVQTNIYAVSQGWLPTNNTQPFVTTIVGLYGLCLQANSGQVWIEDCSSEK [7047.4666] - - -
T13b AEQQWALYADGSIRPQQNR 2231.0952 1116.0512 744.3699 -
T14b DNCLTSDSNIR 1294.5692 647.7882 - -
T15b ETVVK 575.3399 - - -
T16b ILSCGPASSGQR 1232.6052 616.8062 - -
T17b WMFK 611.3010 306.1541 - -
T18b NDGTILNLYSGLVLDVR 1862.0018 931.5045 - -
T19b ASDPSLK 717.3777 359.1925 - -
T20b QIILYPLHGDPNQIWLPLF 2277.2430 1139.1251 759.7525 -
(a) Trypsin digest peptides numbered from the amino terminal of the polypeptide chain. * Main glycopeptide.
Table 4. Ricin E chain B trypsin digest peptides (NCBI Genpept [57] ID: GI:225419), reduced and
carbamidomethylated. Ricin D/E-distinguishing sequence and observed molecular ions are given
in bold.
T# (a) Amino Acid Sequence (M+H)+ (M+2H)2+ (M+3H)3+ (M+4H)4+
T1b ADVCMDPEPIVR 1401.6501 701.3287 - -
T2b IVGR 444.2929 - - -
T3b NGLCVDVR 932.4618 466.7345 - -
T4b DGR 347.1673 - - -
T5b FHNGNAIQLWPCK 1584.7740 792.8906 - -
T6b SNTDANQLWTLK 1390.6961 695.8517 - -
T7b R 175.1189 - - -
T8b DNTIR 618.3205 - - -
T9b SNGK 405.2092 - - -
T10b CLTTYGYPSGVYVMIYDCNTAATDATR 3063.3532 1532.1802 1021.7893 766.5938
T11b glyc WQIWDNGTIINPR - 1496.1530 * 997.7711 * 748.5801 *
T12b glyc SSLVLAATSGNSGTTLTVQTNIYAVSQGWLPTNNTQPFVTTIVGLYGMCLQANSGK [5831.9258] - - -
T13b VWLEDCTSEK 1266.5670 633.7871 - -
T14b AEQQWALYADGSIRPQQNR 2231.0952 1116.0512 744.3699 -
T15b DNCLTTDANIK 1264.5838 632.7955 - -
T16b GTVVK 503.3187 - - -
T17b ILSCGPASSGQR 1232.6052 616.8062 - -
T18b WMFK 611.3010 306.1541 - -
T19b NDGTILNLYNGLVLDVR 1889.0127 945.0100 - -
T20b R 175.1189 - - -
T21b SDPSLK 646.3406 323.6739 - -
T22b QIIVHPVHGNLNQIWLPLF 2238.2545 1119.6309 746.7564 -
(a) Trypsin digest peptides numbered from the amino terminal of the polypeptide chain. * Main glycopeptide.
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Table 5. RCA120 chain A (Uniprot [56] ID: P06750, NCBI Genpept [57] ID: GI:113504) trypsin digest
peptides, reduced and carbamidomethylated. Ricin/RCA120-distinguishing peptides and observed
molecular ions are given in bold.
T# (a) Amino Acid Sequence (M+H)+ (M+2H)2+ (M+3H)3+ (M+4H)4+
T1a IFPK 504.3180 - - -
T2a glyc QYPIINFTTADATVESYTNFIR 3734.6841 * 1867.8457 * 1245.5662 * 934.4265 *
T3a AVR 345.2245 - - -
T4a SHLTTGADVR 1056.5432 528.7752 - -
T5a HEIPVLPNR 1074.6054 537.8063 - -
T6a VGLPISQR 869.5203 435.2638 - -
T7a FILVELSNHAELSVTLALDVTNAYVVGCR 3203.6768 1602.3420 1068.5638 801.6747
T8a AGNSAYFFHPDNQEDAEAITLFTDVQNSFTFAFGGNYDR 4514.0020 2257.5046 1505.3389 1129.2560
T9a LEQLGGLR 885.5152 443.2612 - -
T10a ENIELGTGPLEDAISALYYYSTCGTQIPTLAR 3516.7202 1758.8637 1172.9116 879.9355
T11a SFMVCIQMISEAAR 1642.7750 821.8911 - -
T12a FQYIEGEMR 1172.5404 586.7738 - -
T13a TR 276.1666 - - -
T14a IR 288.2030 - - -
T15a YNR 452.2252 - - -
T16a R 175.1189 - - -
T17a SAPDPSVITLENSWGR 1728.8551 864.9312 - -
T18a LSTAIQESNQGAFASPIQLQ R 2259.1727 1130.0900 753.7291 -
T19a R 175.1189 - - -
T20a NGSK 405.2092 - - -
T21a FNVYDVSILIPIIALMVYR 2239.2559 1120.1316 747.0902 -
T22a CAPPPSSQF 990.4349 495.7211 - -
(a) Trypsin digest peptides numbered from the amino terminal of the polypeptide chain. * Main glycopeptide.
Table 6. RCA120 chain B (NCBI Genpept [57] ID: GI:225114) trypsin digest peptides, reduced and
carbamidomethylated. Ricin/RCA120-distinguishing peptides and observed molecular ions are given
in bold.
T# (a) Amino Acid Sequence (M+H)+ (M+2H)2+ (M+3H)3+ (M+4H)4+
T1b ADVCMDPEPIVR 1401.6501 701.3287 - -
T2b IVGR 444.2929 - - -
T3b NGLCVDVFGEEFTDGNPIQLWPCK 2795.2803 1398.1438 932.4316 699.5755
T4b SNTDWNQLWTLR 1533.7444 767.3758 - -
T5b K 147.1128 - - -
T6b DSTIR 591.3096 - - -
T7b SDGK 406.1932 - - -
T8b CLTISK 721.3913 361.1993 - -
T9b glyc SSPGQQVVIYNCSTATVGATR 3366.4960 * 1683.7516 * 1122.8369 * 842.3795 *
T10b-glyc WQIWDNR 2395.9657 * 1198.4865 * 799.3268 * -
T11b TIINPTSGLVLAATSGNSGTK 2002.0815 1001.5444 668.0320 -
T12b glyc LTVQTNIYAVSQGWLPTNNTQPFVTTIVGLYGMCLQANSGK [4485.2581] - - -
T13b VWLEDCTSEK 1266.5670 633.7871 -
T14b AEQQWALYADGSIRPQQNR 2231.0952 1116.0512 744.3699 -
T15b DNCLTTDANIK 1264.5838 632.7955 - -
T16b GTVVK 503.3187 - - -
T17b ILSCGPASSGQR 1232.6052 616.8062 - -
T18b WMFK 611.3010 306.1541 - -
T19b NDGTILNLYNGLVLDVR 1889.0127 945.0100 - -
T20b R 175.1189 - - -
T21b SDPSLK 646.3406 323.6739 - -
T22b QIIVHPVHGNLNQIWLPLF 2238.2545 1119.6309 746.7564 -
(a) Trypsin digest peptides numbered from the amino terminal of the polypeptide chain. * Main glycopeptide.
In the E isoform of ricin, the amino acid sequence of chain A is identical to that of ricin D. The
differences between D and E are located at the B chain, where approximately half the chain at the
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carboxyl terminal end has the same amino acid sequence as RCA120. In the R. communis cultivar
used here, both ricin isoforms were found. Several peptides detected in the purified ricin preparation
were attributed to ricin E, e.g., T13b, T15b, T19b, and T22b (Table 4).
Besides the sequence GI:225419 [17], two other sequences for ricin E, GI:2169612 and
GI:225896 [18], are published in the NCBI Genpept database (The National Center for Biotechnology
Information, National Library of Medicine, Bethesda, MD, USA) [57]. The peptide molecular ions
at 6162+ and 7463+ matched T17b and T22b of GI:225419 and distinguished it from the other ricin E
sequences (GI:225896, GI:2169612).
The ricin E sequence GI:225419 has a Pro-Ser at position 70–71 [17] identical to that published
for ricin D by the same group [58,59]. Pro70-Ser71 in the T10b peptide from this ricin preparation
could not be confirmed (see Supplementary Information, Figure S1). Instead, data supported Ser-Pro
at position 70–71, which corresponds to other sequences published for ricin E (GI:225896 [18],
GI:2169612) and ricin D (GI:132567 [60]). The discrepancy could be due to an actual difference
between isoforms or flaws in the older data using sequencing methods available at that time.
A comparison to X-ray structures could not be performed, since no structure for the B chain of ricin E
is available so far.
The NCBI database contains a number of sequence variants for the B chain of RCA120, where
sequence GI:225114 differs from other RCA120 sequences, e.g. Uniprot P06750 (NCBI Genpept
GI:113504; X-ray structure: 1RZO). In the purified RCA120 preparation, the two peptides identified as
T9 glycopeptide and T11 of the RCA120 chain B sequence GI:225114 distinguished this isoform from
other RCA120 sequences, e.g., GI:113504 (Table 6; Supplementary Information Figures S2 and S3).
The product ion spectrum of the T3 peptide of chain B, however, was consistent with the amino
acid sequence of GI:113504 and not GI:225114 (Supplementary Information Figure S4). Again, this
inconsistency could be due to lower reliability of older sequencing methods.
Twenty-eight peptides from ricin and 27 from RCA120 were detected by the nano-LC-MS
method used in this investigation. Nineteen of the ricin peptides were proteotypic, i.e., not found in
other proteins including RCA120. For further in-depth characterization, increased sequence coverage
could be obtained on sections resistant to trypsin by using proteases with alternative cleavage
specificity, e.g., chymotrypsin or pepsin.
For identification and quantification, sequence coverage is less important, and instrument
capacity and sensitivity requirements might restrict the number of monitored peptides. Peptides
suitable for identification and quantification of ricin, i.e., proteotypic and detected at high intensity,
are consistent with those proposed earlier [44,61,62] with the exception of T19b, which is polar and
was not retained by the trapping column in the nano-LC system used here. Diagnostic peptides for
ricin with high identification potential observed here were T5, T7, T9, T10, and T11 from the A chain
and T6, T11, T18, and T20 from the B chain. When the sample was reduced and alkylated before
digestion, both T13 from chain A and T14 from chain B (ricin D) also exhibited good electrospray
response and excellent MS/MS sequence information. B chain peptides T3 and T5 were both
prone to deamidation, which made them less suitable as target peptides for quantification and
unequivocal identification.
In RCA120 T6 and T9 from chain A together with T4 from chain B were conserved in all isoforms
and should be selected as primary target peptides for unequivocal identification of RCA120 as well
as T11a when the sample is reduced and alkylated. Ricin E could be distinguished from ricin D by
the B chain peptides highlighted in Table 4, primarily T13, T15, T19, and T22.
Peptides common to ricin and RCA120 suitable for detection and identification of both proteins
when combined with proteotypic peptides were T6, T14, T19, and T20 from chain A and T13 and T16
from chain B of ricin. The disulfide linked peptide connecting the A and B chains in ricin and RCA120
had a relatively low electrospray response, but in samples at toxicologically relevant concentrations
it was useful as an indication of potentially active toxin.
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When matched to the NCBIdatabase, the majority of the diagnostic ricin peptides were unique,
except for T5a which was found in a Pomacea flagellata hemagglutinin (a freshwater snail) and B
chain T3 which appeared in related ribosome-inactivating proteins [44]. The glycopeptide T11b also
matched Viscum album lectin 1 (viscumin) and T19b three other proteins. As the databases continue
to grow, overlaps with both functionally related and purely coincidental new proteins could occur.
Depending on the scenario, the number of peptides required for identification and their sequence
coverage need to be considered. In contrast to recommendations for proteomic identification of
unknown proteins in complex mixtures in the life sciences [63–65], the identification of target proteins
in public health and forensic investigations involves the comparison of experimental data with
authentic reference standards. Criteria for chromatographic retention time and ion ratios as well
as the mass of digestion products and MS/MS sequence information will need to be specified [66].
The World Anti-Doping Agency (WADA) has published detailed identification criteria for
proteins. Reporting of a unique amino acid sequence and minimum sequence coverage of 10%
was specified [67]. Identification criteria for ricin in the context of verification of the Chemical
Weapons Convention was proposed by a working group under the OPCW Scientific Advisory
Board [68]. The MS criteria recommended reporting a minimum of two peptides from each of the
chains with detailed experimental data and, furthermore, that the uniqueness of the peptides needs
to be specified. Supporting data from immunological techniques, ricin functionality assay, molecular
weight determination or PCR was additionally required for unambiguous identification.
Generally, no peptides from other R. communis components were detected in the trypsin
digests of purified ricin and purified RCA120, e.g., 2S-albumin or the peptide biomarkers RCB-1
to -3 [69]. The next step was to analyze potential cross-contaminations of RCA120 in the purified
ricin preparation and, vice versa, ricin in the purified RCA120 preparation. The concentration of the
impurities in the preparations was calculated using the protein concentrations obtained from UV280
measurement and the responses of peptides specific for ricin and RCA120.
The amount of RCA120 in the purified ricin sample was calculated from the peak areas
determined from the extracted ion chromatograms, using the RCA120 preparation as the analytical
standard. Similarly, the amount of ricin in purified RCA120 was determined using the ricin
preparation as the analytical standard. Based on this procedure, the amount of RCA120 in the
ricin preparation was 1.4% ˘ 0.4% relative to ricin based on the average of chain A peptides, and
4.5% ˘ 1.5% based on chain B peptides. Therefore, the purity of ricin was specified toě97% based on
the average of chain A and B peptides.
For the R. communis agglutinin preparation, the amount of ricin found was 0.5% ˘ 0.2%
calculated for chain A peptides and 1.4%˘ 0.7% for chain B peptides, resulting in an average purity of
>99%. For both protein preparations, these results were in good agreement with the purity estimated
from CGE analysis.
Overall, the purity of the ricin and the RCA120 preparation characterized in this work was
very good. While for a commercial preparation of ricin a similar purity of 96% was reported,
the corresponding RCA120 preparation showed a purity of only 68% [43]. Additionally, our
toxin preparations were derived from a defined R. communis cultivar, while the cultivar used for
purification concerning the commercial products is not known.
As described above, the concentration of RCA120 in the purified ricin sample was consistently
higher when calculated using chain B peptides than peptides from chain A. The same observation
was made for ricin in the purified RCA120 sample. This was unexpected, considering the nature
of the sample and the purification scheme used. The purification process consisted of an acid
extraction at pH 4 and ammonium sulfate precipitation of proteins. Affinity separation using
a lactosyl-Sepharose-4B column was performed to isolate ricin and RCA120 from other constituents
in the precipitate. Finally, size exclusion chromatography was used to separate ricin from RCA120.
A possible explanation for the excess of chain B peptides over chain A peptides measured as
contamination in both preparations could be a decomposition process or a reduction of the A–B
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interchain disulfide bond during the extraction and precipitation process. Chain B of both ricin
and RCA120 would be isolated together with the intact proteins in the affinity step and could end
up in the ricin size exclusion chromatography fraction to an extent depending on the size exclusion
separation efficiency.
The amount of ricin E was determined in the ricin preparation using the chain B peptides that
distinguish the E isoform from ricin D (Table 4). However, since they are shared with RCA120, the
result had to be corrected by the content of RCA120 which can be determined from the intensity of the
relevant RCA120 peptides, e.g., T6, T9, and T11 from chain A and T3 and T4 from chain B. Based on
this procedure, the ratio of ricin D to ricin E was estimated to be close to one for the ricin preparation
purified from R. communis carmencita in this work (data not shown).
2.2.2. Analysis of Trace Contaminants by MALDI-TOF MS/MS Analysis
The aim of the following experiments was to identify any impurities which might be
present in both the ricin and the RCA120 preparation. As described in Section 2.1.1, the
separation of larger amounts of both purified proteins by SDS-PAGE resulted in a number of faint
lower-molecular-weight protein bands of unknown identity (Figure 2). It has remained unclear from
the experiments conducted so far whether these protein bands were fragmented ricin or RCA120
proteins or irrelevant contaminants co-purified from the seeds. Therefore, both purified preparations
were separated on an SDS-PAGE, and Coomassie-stained bands were cut out, and proteins were
reduced, alkylated, and digested with trypsin, followed by a MALDI-TOF MS/MS analysis.
Figure 8 shows the Coomassie-stained gel which was used to cut out protein bands. The gel
pieces corresponding to the individual protein bands were numbered sequentially R1 through R5 for
the purified ricin preparation and A1 through A8 for the purified RCA120 preparation.
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Figure 8. Separation of purified ricin and RCA120 by gel electrophoresis for subsequent 
MALDI-TOF MS/MS analysis. Purified ricin (15.1 µg, left) or purified RCA120 (10.3 µg, 
right) were separated on a 10% SDS-PAGE. The indicated protein bands were cut out for 
further analysis: bands R1 through R5 for ricin and bands A1 through A8 for RCA120, 
respectively. For an in-gel digest, bands were cut out, reduced, and alkylated, used for tryptic 
digestion, and finally eluted from the gel, followed by MALDI-TOF MS/MS analysis. 
Figure 8 shows the Coomassie-stained gel which was used to cut out protein bands. The gel pieces 
corresponding to the individual protein bands were numbered sequentially R1 through R5 for the purified 
ricin preparation and A1 through A8 for the purified RCA120 preparation.  
Figure 9 shows an overview of resulting mass spectra of trypsin-digested ricin and RCA120 bands. 
All ricin bands showed similar mass spectral patterns, except for band 2, presumably because of a lower 
protein amount. For the purified RCA120 preparation, all mass spectra were similar, except for bands 5 
and 8, again presumably because of low protein amounts analyzed. 
Tables 7–9 list the specific peptides identified as products of trypsin digestion from chains A and B 
of ricin D (Uniprot [56] ID: P02879) as well from chain B of ricin E (Uniprot [56] ID: Q41143) which 
could be found in the mass spectra of the indicated gel bands.  
All ricin bands R1 to R5 contained ricin chains A and B. Ricin E chain B could be observed in the 
ricin bands 1, and 3 to 5. Cross-contamination of RCA120 in the ricin preparation was found in bands 
R1 and R3, but only in one RCA120 peptide fragment (m/z 1533, SNTDWNQLWTLR). Based on these 
data, cross-contamination of RCA120 in the ricin preparation was very low, corroborating results 
obtained by the LC-ESI MS/MS analysis. 
Figure 8. Separation of purified ricin and RCA120 by gel electrophoresis for subsequent MALDI-TOF
MS/MS analysis. Purified ricin (15.1 µg, left) or purified RCA120 (10.3 µg, right) were separated on
a 10% SDS-PAGE. The indicated protein bands were cut out for further analysis: bands R1 through
R5 for ricin and bands A1 through A8 for RCA120, respectively. For an in-gel digest, bands were cut
out, reduced, and alkylated, used for tryptic digestion, and finally eluted from the gel, followed by
MALDI-TOF MS/MS analysis.
Figure 9 shows an overview of resulting mass spectra of trypsin-digested ricin nd RCA120
bands. All ricin bands showed similar mass spectral patterns, except for band 2, presumably because
of a lower protein am unt. For the purified RCA120 preparation, all mass s ectra were similar, exc pt
for bands 5 and 8, again presumably because of low protein amounts analyzed.
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Tables 7–9 list the specific peptides identified as products of trypsin digestion from chains A and
B of ricin D (Uniprot [56] ID: P02879) as well from chain B of ricin E (Uniprot [56] ID: Q41143) which
could be found in the mass spectra of the indicated gel bands.
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Table 7. Ricin D chain A-specific peptides obtained by trypsin digestion (Uniprot [56] ID: P02879,
NCBI Genpept [57] ID: GI:132567) with one missed cleavage, reduced and carbamidomethylated in
the mass range of 600–4000, and obtained by mass spectrometry analysis of the respective gel bands.
Position Amino Acid Sequence (M+H)+ R1 * R2 * R3 * R4 * R5 *
67–74 VGLPINQR 896.5312 x - - x x
161–169 LEQLAGNLR 1013.5738 x x - x x
150–160 YTFAFGGNYDR 1310.5800 x x x x x
190–203 SFIICIQMISEAAR 1638.8342 x x x x x
67–83 LTTGADVRHEIPVLPNR 1888.0399 x - x x x
150–169 YTFAFGGNYDRLEQLAGNLR 2305.1360 x - x x x
121–149 AGNSAYFFHPDNQEDAEAITHLFTDVQNR 3307.5038 x - x x x
* R1–R5: Ricin band number of the one-dimensional gel electrophoresis; please compare Figure 8. Indicated
by “x” is the presence of the respective trypsin digest peptide shown.
Table 8. Ricin D chain B-specific peptides obtained by trypsin digestion (Uniprot [56] ID: P02879,
NCBI GenPept [57] ID: GI:132567) with one missed cleavage, reduced and carbamidomethylated in
the mass range of 600–4000, and obtained by mass spectrometry analysis of the respective gel bands.
Position Amino Acid Sequence (M+H)+ R1 * R2 * R3 * R4 * R5 *
355–366 SNTDANQLWTLK 1390.6961 x - x - -
355–367 SNTDANQLWTLKR 1546.7972 x x x x x
330–342 FHNGNAIQLWPCK 1584.7740 x - x x -
534–550 NDGTILNLYSGLVLDVR 1862.0018 x - x x x
365–391 CLTTYGYSPGVYVMIYDCNTAATDATR 3063.3532 x x x x x
* R1–R5: Ricin band number of the one-dimensional gel electrophoresis; please compare Figure 8. Indicated
by “x” is the presence of the respective trypsin digest peptide shown.
Table 9. Ricin E chain B-specific peptides obtained by trypsin digestion (Uniprot [56] ID: Q41143) with
one missed cleavage, reduced and carbamidomethylated in the mass range of 600–4000, and obtained
by mass spectrometry analysis of the respective gel bands.
Position Amino Acid Sequence (M+H)+ R1 * R2 * R3 * R4 * R5 *
220–236 NDGTILNLYNGLVLDVR 1889.0127 x - x x x
* R1–R5: Ricin band number of the one-dimensional gel electrophoresis; please compare Figure 8. Indicated
by “x” is the presence of the respective trypsin digest peptide shown.
All ricin bands R1 to R5 contained ricin chains A and B. Ricin E chain B could be observed in
the ricin bands 1, and 3 to 5. Cross-contamination of RCA120 in the ricin preparation was found in
bands R1 and R3, but only in one RCA120 peptide fragment (m/z 1533, SNTDWNQLWTLR). Based
on these data, cross-contamination of RCA120 in the ricin preparation was very low, corroborating
results obtained by the LC-ESI MS/MS analysis.
The corresponding specific trypsin digest peptides from RCA120, Uniprot [56] ID: P06750, are
displayed in Tables 10 and 11. In the RCA120 preparation, only RCA120 peptides (Uniprot [56]
ID: P06750) and no ricin peptides were detected by MALDI-TOF MS analysis. Measured peptides
belonged to RCA120 chains A and B, while band 8 showed peptides for RCA120 chain B only.
In summary, one-dimensional gel electrophoresis showed that the ricin preparation can be
separated into five distinct bands with one main fragment at about 63 kDa, whereas purified RCA120
can be separated into eight bands with two main fragments running at around 170 kDa. The identity
of the ricin and RCA120 bands was verified by MALDI-TOF-MS/MS analysis after trypsin digestion.
All ricin bands contained ricin chains A and B of ricin D (Uniprot [56] ID: P02879). Ricin bands 1
and 3 to 5 also contained ricin E (Uniprot [56] ID: Q41143), while bands R1 and R3 also contained
one peptide fragment (m/z 1533, SNTDWNQLWTLR) of RCA120. The cross-contamination was
negligible. In purified RCA120 only RCA120 (Uniprot [56] ID: P06750) and no ricin was detected.
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Measured peptides belonged to RCA120 chains A and B, while band 8 only showed peptides for
RCA120 chain B. Most importantly, the MALDI-TOF-MS/MS experiments gave no indication of the
presence of irrelevant proteins co-purified from the R. communis seeds.
Table 10. RCA120 chain A-specific peptides obtained by trypsin digestion (Uniprot [56] ID: P06750,
NCBI Genpept [57] ID: GI113504) with one missed cleavage, reduced and carbamidomethylated in
the mass range of 600–4000, and obtained by mass spectrometry analysis of the respective gel bands.
Position Amino Acid Sequence (M+H)+ A1 * A2 * A3 * A4 * A5 * A6 * A7 * A8 *
73–80 VGLPISQR 869.5203 x x - - - - - -
150–157 LEQLGGLR 885.5152 x x x x - x - -
190–203 SFMVCIQMISEAAR 1642.7750 x x x x x x - -
64–80 HEIPVLPNRVGLPISQR 1925.1079 x x - - - - - -
263–281 FNVYDVSILIPIIALMVYR 2238.2545 x x x x - x x -
158–189 ENIELGTGPLEDAISALYYYSTCGTQIPTLAR 3516.7202 x x x x - x - -
* A1–A8: RCA120 band number of the one-dimensional gel electrophoresis; please compare Figure 8. Indicated
by “x” is the presence of the respective trypsin digest peptide shown.
Table 11. RCA120 chain B-specific peptides obtained by trypsin digestion (Uniprot [56] ID: P06750,
NCBI Genpept [57] ID: GI225114) with one missed cleavage, reduced and carbamidomethylated in
the mass range of 600–4000, and obtained by mass spectrometry analysis of the respective gel bands.
Position Amino Acid Sequence (M+H)+ A1 * A2 * A3 * A4 * A5 * A6 * A7 * A8 *
343–354 SNTDWNQLWTLR 1533.7444 x x x x x x x x
343–355 SNTDWNQLWTLRK 1661.8394 x x x x x x x x
319–342 NGLCVDVFGEEFTDGNPIQLWPCK 2795.2803 x x x x - x x x
* A1–A8: RCA120 band number of the one-dimensional gel electrophoresis; please compare Figure 8. Indicated
by “x” is the presence of the respective trypsin digest peptide shown.
2.3. Detection of Ricin and RCA120 Using Antibody-Based Techniques
In a next step, both the ricin and the RCA120 preparation purified in this work were detected
using immunological methods. Two different sandwich enzyme-linked immunosorbent assays
(ELISA) were used, one preferentially detecting ricin with only little cross-reactivity with RCA120 and
the other one preferentially detecting RCA120 with low cross-reactivity with ricin. The ricin-specific
ELISA was based on a combination of two monoclonal antibodies and detected both chains of
ricin (R109 and R18 [70], Table 12), while the RCA120-specific ELISA combined a monoclonal with
a polyclonal chicken antibody (mAb ARK4 [71] and chicken IgY RC22 [72], Table 12).
Table 12. Monoclonal and polyclonal antibodies used for immunological detection.
Name Isotype
Specificity Indirect ELISA Sandwich ELISA
Ricin RCA120 A Chain B Chain Ricin RCA120
R18 mAb, IgG1κ +++ + +++ - +++ +
R109 mAb, IgG1κ +++ ++++ - +++ ++++ +
ARK4 § mAb, IgG + ++++ n.d. n.d. + +++
RC22 pAb, IgY ++++ ++++ ++++ ++++ +++ +++
§ mAb ARK4 kindly provided by M. Avondet, Spiez Laboratory, Switzerland; reactivity of the indicated
antibodies to ricin, RCA120, ricin A chain or ricin B chain is qualitatively indicated: - no reaction, + weak
reaction, +++ strong reaction, ++++ very strong reaction; n.d., not determined.
In a validation study for the ricin-specific ELISA, the half maximal effective concentration (EC50)
of the ELISA as the point of highest precision with respect to quantification was determined at
115 ˘ 32 pg/mL with a limit of detection of 2 pg/mL. The working range of the ricin-specific ELISA
as the range in which obtained results have a precision of <20% and a trueness of 80%–120% was
experimentally determined, and the lower and upper limits of quantification were determined at
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5 pg/mL and 708 pg/mL, respectively. Intra-assay and inter-assay coefficients of variation were
determined at 6% and 13% at the EC50 value, respectively, with n = 10 as the number of intra- or
inter-assay repetitions performed in duplicate (data not shown).
Using this ELISA, purified ricin could be detected down to around 3 pg/mL (Figure 10a). In
order to test for specificity, the related RCA120 was analyzed using the same sandwich ELISA. As
shown in Figure 10a, when equivalent concentrations of ricin and RCA120 were tested in parallel,
ricin was preferentially detected (300-fold difference at the EC50). However, at concentrations above
4 ng/mL, RCA120 was detected as well. No cross-reactivity except for RCA120 to a broad range
of other lectins and toxins was detected (data not shown). Still, based on the observed reactivity to
both analytes, in a mixture containing ricin along with RCA120, assuming that both proteins were
present in significant amounts, the ELISA would not be able to distinguish both molecules reliably.
An alternative interpretation of the data would be that the ricin-specific ELISA is specific for ricin only
and detects the minute contamination of ricin within the RCA120 preparation (below 1% according
to 2.2.1); this seems unlikely on the basis of the high sequence homology between both analytes,
but cannot be ruled out since the precise epitopes recognized by both mAbs are not known. With
respect to sensitivity, this ELISA is among the most sensitive sandwich ELISAs published to date.
Various ELISAs have been developed by different groups [70,73–83]. Only a few of them are able to
quantify ricin with detection limits down to a few pg/mL with limits of detection of 10 fg/mL [84],
2 pg/mL [70], 8 pg/mL [85], and 40 pg/mL [86]. Several ricin-specific ELISAs developed in different
laboratories have been evaluated in a common ricin proficiency test panel organized in the framework
of the EQuATox project, and results are presented in different manuscripts in this special issue of
Toxins [42,87].
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Figure 10. Sandwich ELISA for detection of purified ricin and purified RCA120.  
(a) A sandwich ELISA preferentially detecting ricin based on mAb R109 as capture antibody 
and biotinylated mAb R18 as detection antibody was used to measure serial dilutions of the 
purified ricin (red) or purified RCA120 (green) preparation. (b) A sandwich ELISA 
preferentially detecting RCA120 based on mAb ARK4 as capture reagent and biotinylated 
pAb RC22 as detection reagent was used to measure serial dilutions of ricin (red) or RCA120 
(green). Both ELISAs were amplified using a polyHRP-conjugate and TMB substrate. 
Absorption was measured at 450 nm with a reference wavelength of 620 nm. The absorption 
was plotted against the logarithmic concentrations of ricin or RCA120, respectively. Results 
displayed are based on two independent experiments performed in duplicate each. Inset: 
enlargement showing the low concentration range (linear) and estimated limit of detection 
(LOD = mean of blank + 3.29 × SD). 
Using the combination of mAb ARK4 with pAb RC22, purified RCA120 could be detected with a 
limit of detection around 1 pg/mL (Figure 10b). The EC50 was determined at 117 pg/mL ± 27 pg/mL. 
The working range of the agglutinin-specific ELISA (precision of <20%; trueness of 80%–120%) was 
experimentally determined and the lower and upper limits of quantification were determined at 3 pg/mL 
and 1549 pg/mL, respectively. Intra-assay and inter-assay coefficients of variation were determined at 
4% and 6% at the EC50 value, respectively, with n = 10 as number of intra- or inter-assay repetitions 
performed in duplicate (data not shown). 
When equivalent concentrations of RCA120 and ricin were tested in parallel with this  
RCA120-specific ELISA, RCA120 was preferentially detected (100-fold difference at the EC50). Again, 
at concentrations above 1 ng/mL, ricin was detected as well (Figure 10b). Similar to the above, in a 
mixture containing significant amounts of ricin along with RCA120, the ELISA would not be able to 
distinguish both molecules reliably.  
With respect to the ricin PT organized in the framework of the EQuATox project, both ELISAs were 
used to quantify the sample materials offered after spiking the purified ricin or RCA120 preparations 
into different liquid matrices (see this issue of Toxins: [42]). 
2.4. Functional Activity of Ricin and RCA120 
Ricin is a lectin and functions as an enzyme within the body: after binding to distinct carbohydrate 
structures on the cell surface via its B chain, the molecule is internalized and the A chain removes a 
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Figure 10. Sandwich ELISA for detection of purified ricin and purified RCA120. (a) A sandwich
ELISA preferentially detecting ricin bas d on mAb R109 as capture antibody and biotinylated
mAb R18 as detection antibody was used to measure serial dilutions of the purified ricin (red)
or purified RCA120 (green) preparation; (b) A sandwich ELISA preferentially detecting RCA120
based on mAb ARK4 as capture reagent and biotinylated pAb RC22 as detection reagent was used
to measure serial dilutions of ricin (red) or RCA120 (green). Both ELISAs were amplified using
a polyHRP-conjugate and TMB substrate. Absorption was measured at 450 nm with a reference
wavelength of 620 nm. The absorption was plotted against the logarithmic concentrations of ricin
or RCA120, respectively. Results displayed are based on two independent experiments performed in
du licate each. Inset: enlargement showing the low co entration range (linear) and estimated limit
of detection (LOD = mean of blank + 3.29 ˆ SD).
Using the combination of mAb ARK4 with pAb RC22, purified RCA120 could be detected
with a limit of detection around 1 pg/mL (Figure 10b). The EC50 was determined at 117 pg/mL
˘ 27 pg/ L. The working range of the agglutinin-specific ELISA (precision of <20%; trueness of
80%–120%) was experimentally determined and the lower and upper limits of quantification were
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determined at 3 pg/mL and 1549 pg/mL, respectively. Intra-assay and inter-assay coefficients of
variation were determined at 4% and 6% at the EC50 value, respectively, with n = 10 as number of
intra- or inter-assay repetitions performed in duplicate (data not shown).
When equivalent concentrations of RCA120 and ricin were tested in parallel with this
RCA120-specific ELISA, RCA120 was preferentially detected (100-fold difference at the EC50). Again,
at concentrations above 1 ng/mL, ricin was detected as well (Figure 10b). Similar to the above, in
a mixture containing significant amounts of ricin along with RCA120, the ELISA would not be able
to distinguish both molecules reliably.
With respect to the ricin PT organized in the framework of the EQuATox project, both ELISAs
were used to quantify the sample materials offered after spiking the purified ricin or RCA120
preparations into different liquid matrices (see this issue of Toxins: [42]).
2.4. Functional Activity of Ricin and RCA120
Ricin is a lectin and functions as an enzyme within the body: after binding to distinct
carbohydrate structures on the cell surface via its B chain, the molecule is internalized and the
A chain removes a single adenine from the 28S rRNA of the ribosome, preventing further binding
of elongation factors. This leads to an arrest of protein synthesis and finally results in cell death.
Different in vitro assays have been developed to detect the functional activity of ricin, among them
assays that detect the glycan-binding capacity of the B chain [88] or assays that detect the isolated
enzymatic activity such as adenine release assays or cell-free translation assays based on rabbit
reticulocyte lysate [43,89,90]. Since the detection of the activity of the isolated subchains provides only
limited information on the activity of the intact ricin molecule, assays for both subchains are required
for the detection of active ricin. In this context, cytotoxicity assays have found broad application,
ranging from end-point assays to real-time cytotoxicity formats [45].
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and RCA120 preparations. Vero cells were seeded in a 96-well E-plate at 12,500 cells/well; 
immediately after seeding, cells were exposed to different concentrations of ricin (red) or 
RCA120 (green). Cell proliferation was dynamically monitored over 36 h using an xCelligence 
instrument (OMNI Life Science GmbH & Co, Bremen, Germany [45]). For calculation of 
the IC50 values of ricin and RCA120, the percentage of cells alive was plotted against the 
concentration of ricin (red) or RCA120 (green) at 36 h. Cell index of cells without treatment 
at 20 h was set to 100%. Calculated IC50 for ricin was 0.2 ng/mL and for RCA120 60 ng/mL. 
One representative experiment out of two performed in triplicate is shown. 
In this work, a real-time cytotoxicity assay based on impedance measurement was used to characterize 
both the purified ricin and the purified RCA120 preparation [45]. The cell proliferation and  
toxin-induced cell death of African green monkey (Vero) cells was monitored online using the 
xCELLigence system (OMNI Life Science GmbH & Co. KG, Bremen, Germany). This system is based 
on an impedance sensor technology to quantify cell viability and proliferation noninvasively and without 
labeling. Cell proliferation, morphology, and adhesion are monitored in real time. Cells are seeded into 
E-plates with integrated microelectrodes. Upon low-voltage application an electric field is generated 
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Figure 11. Real-time cytotoxicity assay to display the cytotoxic activity of the purified ricin and
RCA120 preparations. Vero cells were seeded in a 96-well E-plate at 12,500 cells/well; immediately
after seeding, cells were exposed to different concentrations of ricin (red) or RCA120 (green). Cell
proliferation was dynamically monitored over 36 h using an xCelligence instrument (OMNI Life
Science GmbH & Co, Bremen, Germany [45]). For calculation of the IC50 values of ricin and RCA120,
the percentage of cells alive was plotted against the concentration of ricin (red) or RCA120 (green)
at 36 h. Cell index of cells without treatment at 20 h was set to 100%. Calculated IC50 for ricin
was 0.2 ng/mL and for RCA120 60 ng/mL. One representative experiment out of two performed in
triplicate is shown.
In this work, a real-time cytotoxicity assay based on impedance measurement was used to
characterize both the purified ricin and the purified RCA120 preparation [45]. The cell proliferation
and toxin-induced cell death of African green monkey (Vero) cells was monitored online using the
xCELLigence syste (OMNI Life Science GmbH & Co. KG, Bremen, Germany). Thi system is b sed
on an impedance sensor technology to quantify cell viability and proliferation noninvasively and
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without labeling. Cell proliferation, morphology, and adhesion are monitored in real time. Cells are
seeded into E-plates with integrated microelectrodes. Upon low-voltage application an electric field
is generated which is differentially modulated by the cells. The higher the number of cells attached to
the plate surface, the higher the impedance monitored by the instrument is. This change in impedance
is used as a read-out for cell viability [45].
Using a standardized protocol, Vero cells were incubated over 36 h with increasing
concentrations of purified ricin or purified RCA120. In vitro cytotoxicity, where 50% of the cells
were alive (IC50), was calculated after 36 h by displaying the percentage of cells alive against the
concentration of the lectin used in the test (Figure 11). For ricin, an IC50 of 0.2 ng/mL was calculated,
while for RCA120, an IC50 of 60 ng/mL was determined. Based on these data, ricin is approximately
300-fold more toxic than RCA120 in the experimental system used. While it is well established that
RCA120 is much less toxic than ricin, the difference in activity depends on the type of assay as well
as on the purity and integrity of the lectin preparations used; differences in activity from 60-fold to
2000-fold can be found in the literature [8,22–24].
3. Experimental Section
3.1. Purification of Ricin and RCA120 and Determination of Protein Concentration
Ricin and RCA120 were purified from the seeds of R. communis variety carmencita pink following
protocols similar to those described earlier [8,45,46]. Briefly, the purification process consisted of
an acid extraction at pH 4 and an ammonium sulfate precipitation of proteins. Affinity separation
using an in-house prepared lactosyl-Sepharose-4B column was used to isolate ricin and RCA120 from
other constituents in the precipitate. Finally, size exclusion chromatography over HiLoad Superdex
200 prep grade (General Electrics, Health Care Life Sciences, Uppsala, Sweden) was used to separate
ricin from RCA120.
For determination of the precise concentration of the purified ricin and purified agglutinin
preparations, the absorption at 280 nm, 260 nm, and 320 nm were measured in four independent
dilutions using a NanoPhotometer (Implen, Munich, Germany) on two different days. Each dilution
was measured five times. PBS was used as diluent and as blank reference. The average of the
absorption values of each dilution was used to calculate the concentration of both toxin preparations
according to Lambert-Beer’s law:
c “ A280
ε
ˆDFˆ d
with c: concentration; A280: absorption at 280 nm; ε: extinction coefficient; DF: dilution factor; d:
path length of cuvette and the following extinction coefficients: ε (ricin) = 1.1615 mL ˆmg´1 ˆ cm´1
(experimentally determined by Russmann et al. [52]), which was highly similar to ε (ricin) = 1.17 mL
ˆmg´1 ˆ cm´1 determined earlier and ε (agglutinin) = 1.17 mL ˆmg´1 ˆ cm´1 [6].
3.2. SDS-PAGE
Ten percent SDS gels were run in a Mini-PROTEANr 3 System (Bio-Rad Laboratories, Munich,
Germany). Proteins were separated either under non-reducing conditions or under reducing
conditions using β-mercaptoethanol (β-ME, SERVA Electrophoresis GmbH, Heidelberg, Germany)
as reducing agent, followed by staining with Coomassie Brilliant Blue G250 (SERVA Electrophoresis
GmbH, Heidelberg, Germany).
3.3. Capillary Gel Electrophoresis
A Bio-Rad Experion electrophoresis instrument (Bio-Rad Laboratories, Hercules, CA, USA) was
used with Pro260 chips and the manufacturer’s reagent kit. Four µL of sample were mixed with the
sample buffer and analyzed according to the manufacturer’s protocol.
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3.4. LC-ESI MS for Determination of Molecular Weight
The LC-ESI MS measurements were carried out using the Thermo Finnigan LXQ linear ion trap
mass spectrometer (Thermo Scientific, Waltham, MA, USA). The LC separation was done with the
Thermo Finnigan Surveyor liquid chromatograph (Thermo Scientific, Waltham, MA, USA) using
Supelco Discovery BIO Wide Pore C5 column (Sigma-Aldrich, Bellefonte, PA, USA) (100 ˆ 2.1 mm,
3 µm particles, 300 Å pore size).
The LC separation was done using a gradient program: 0–7 min 5%–50% B, 7–16 min 50%–95% B,
16–21 min 95% B, 21–22 min 95%–5% B, 22–32 min 5% B, where eluent A is ultra high quality water
(reverse osmosis and ion exchange) with 0.1% of formic acid, and B is acetonitrile with 0.1% of formic
acid. The injection volume was 10 µL.
The mass range for the measurements was 400–2000 m/z and the spectra were measured in the
profile mode. The voltage of the ESI needle was 4 kV. The ion source capillary was kept at 290 ˝C and
at 42 V. Sheat gas was kept at 20 (arbitrary units) and Aux gas at 4 (arb). Deconvolution was done
using ProMass for Xcalibur (version 2.8, rev. 2, Novatia LLC, Newtown, PA, USA).
3.5. LC-ESI MS for Tryptic Fingerprint and Sequencing
For LC-MS analysis aliquots of purified ricin and purified RCA120 were digested with trypsin
after reduction and alkylation according to published procedures [44]. Sample preparation and
digestion was performed directly in a centrifugal cartridge with a 10 kDa molecular weight cut-off
membrane (Microcon YM-10, Merck Millipore, Billerica, MA, USA). Briefly, 50 µL of the sample were
transferred to the cartridge and centrifuged at 14,000ˆ g until approximately 10 µL remained. The
reducing solution, 200 µL of 3 mg DTT/mL in guanidine buffer (6 M guanidine HCl in 0.1 M Tris pH 8)
was added and the sample was reduced at 60 ˝C for 1 h. Then, 67 µL of 7.5 mg iodoacetamide/mL
in the guanidine buffer was added and the sample was alkylated at 37 ˝C in the dark for 30 min. The
reduced and alkylated sample was centrifuged to approximately 10 µL and washed twice with 200 µL
of 0.1 M ammonium bicarbonate. The digestion buffer, 200 µL of 0.1 M ammonium bicarbonate, and
0.5 µg of modified trypsin (Promega, sequencing grade) was added and the sample was digested for
6 h at 37 ˝C before centrifugation to collect the digest peptides. The digests were stored at ´20 ˝C
until analysis.
A Waters nano-Acquity-Q-Tof Ultima LC-MS system equipped with a nanoflow electrospray
ionization source was used for sample analysis (Micromass, Altrincham, UK). Digests were diluted
1:50 in 0.4% formic acid containing 5 fmol/µL of leucine-enkephalin internal standard. A 2-µL sample
was injected and trapped on a C18 trap column which was subsequently eluted onto a Waters BEH130
C18 75 µm in diameter, 150 mm column with a 3%–60% acetonitrile gradient containing 0.1% formic
acid at 400 nL/min. The mass scale was calibrated using sodium formate clusters. Mass spectra were
acquired over the mass range 300–1800 at 1 scan/s. Precursor ions were selected with a 3 Da mass
window, and product ion spectra were recorded from 100 and up to a mass appropriate for each of
the precursor ions.
3.6. MALDI TOF-MS
First, 15.1 µg of ricin and 10.3 µg of RCA120 were separated on a non-reducing 10% SDS-PAGE.
Coomassie-stained gel bands were cut out with a clean scalpel, divided into equal sections of
approximately 1.5 mm size, and transferred into Eppendorf (Hamburg, Germany) LoBind tubes. In
order to destain the protein bands, gel pieces were covered twice with 200 µL of 200 mM ammonium
bicarbonate/40% acetonitrile for 30 min at 37 ˝C. Reduction was performed with 15 µL of 400 mM
dithiothreitol for 10 min at 95 ˝C. Alkylation was carried out using 30 µL of 500 mM iodoacetamide
at 37 ˝C for 30 min in the dark. Reduced and alkylated samples were digested with 20 µL of trypsin
(0.4 µg) (Sigma-Aldrich, Taufkirchen, Germany, proteomics grade) at 37 ˝C overnight. Reaction was
terminated with 50 µL of 0.1% trifluoroacetic acid/50% acetonitrile, for 30 min at 37 ˝C. Digested
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peptides were further desalted and concentrated with ZipTip C18 resin (Merck Millipore, Darmstadt,
Germany) carried out according to manufacturer’s instructions.
Sample analysis was done utilizing an autoflex speed MALDI-TOF/TOF mass spectrometer
(Bruker Daltonics, Bremen, Germany) with a polished steel MTP 384 target plate (Bruker Daltonics,
Bremen, Germany). One µL sample was mixed with 1 µL of α-Cyano-4-hydroxycinnamic acid
(12 mg/mL; Bruker Daltonics, Bremen, Germany), and 1 µL was deposited on the target to let
it dry. For matrix suppression deflection was set to 600, and mass spectra were acquired over
the mass range 600–4000. External calibration was performed with peptide calibration standard II
(Bruker Daltonics, Bremen, Germany). Spectra were processed by flexAnalysis 2.4 and BioTools
3.2 software (Bruker Daltonics, Bremen, Germany).
3.7. ELISA
The ricin-specific ELISA was performed essentially as described before [70], using mAb
antibody R109 as capture antibody and biotinylated R18 as detection tool, followed by
a streptavidin-poly-horseradish peroxidase conjugate (PolyHRP40). Briefly, MaxiSorp microtiter
plates were coated with primary mAb (10 µg/mL) in 50 µL of PBS overnight at 4 ˝C and
blocked with casein buffer (Senova, Jena, Germany) for 1 h at room temperature. Following
washing, 50 µL of toxin was added in serial dilutions from 100 ng/mL to 0.05 pg/mL in
assay buffer (PBS, 0.1% BSA (Sigma-Aldrich, Munich, Germany)) and incubated for 2 h at
room temperature. The sandwich ELISA was developed by incubation with biotin-labeled
secondary antibody diluted in casein buffer (1 h, room temperature), followed by washing
and detection with Streptavidin-PolyHRP40 (0.5 ng/mL, Senova, Jena, Germany) and substrate
3,31,5,51-tetramethylbenzidine (TMB, Seramun Diagnostica GmbH, Heidesee, Germany).
The RCA120-specific ELISA was performed similarly, using mAb ARK4 (kindly provided by
Marc-André Avondet, Spiez Laboratory, Switzerland; [71]) as capture antibody and biotinylated
polyclonal chicken IgY RC22 [72] as detection antibody.
3.8. Cytotoxicity Assay
Measurement of the cytotoxicity of ricin and RCA120 was performed by a real-time cytotoxicity
assay based on impedance measurement (xCELLigence system, OMNI Life Science GmbH & Co,
Bremen, Germany) as described before [45]. Briefly, after baseline measurement of the E-plate, a Vero
cell suspension containing 12,500 cells/well in a volume of 75 µL was seeded into the E-plates.
Immediately after the seeding of cells into the wells (i.e., without prior attachment of the cells onto the
plate), purified ricin or purified RCA120 at concentrations of 0.064 ng/mL to 200 ng/mL for ricin or
0.128 ng/mL to 400 ng/mL for RCA120 were added onto the cells in a volume of 30 µL. Each sample
was measured at least in duplicate. The cell index was automatically determined every 15 min by
the xCELLigence system over a period of up to 36 h. During the incubation, only live cells attached
onto the plate and showed vigorous proliferation (equivalent to an increase in impedance and cell
index). Depending on the toxin concentration present on the cells, the proliferation was terminated
after different time points, followed by detachment and cell death (equivalent to a drop of impedance
and cell index). Cell viability was converted into percent (%) of the control cells alive over toxin
concentration. To this end, the cell index of nontreated cells measured at several time-points was set
to 100%, and for a given time-point the ratio of cell index values of toxin-treated cells to untreated cells
was calculated. In vitro cytotoxicity at 50% (IC50) was defined as the toxin concentrations required to
reduce cell viability by 50% compared to untreated control cells [45].
4. Conclusions
Although different technologies for the detection and identification of the plant toxin ricin as
a potential biological weapon under the BWC and CWC have been established worldwide, hardly
any universally agreed-upon “gold standards” are available, i.e., common internationally recognized
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reference materials. The current situation is that expert laboratories use differently purified in-house
materials of variable quality for their own validation purposes, making any comparison of accuracy
and sensitivity of different methods nearly impossible. The current work has been undertaken in
an effort to generate highly pure and well-characterized materials that can be used as a starting point
to develop certified reference materials.
In this work, the plant toxin ricin and the highly homologous R. communis agglutinin RCA120
were purified from the seeds of R. communis variety carmencita pink to a purity of >97% and
>99%, respectively. Both protein preparations were extensively characterized using biochemical,
spectrometric, immunological, and functional approaches combining technical expertise available
in different European laboratories in the framework of the EU-funded project EQuATox. Based
on the in-depth characterization performed in different European expert laboratories, the protein
preparations represent reference materials of high quality which were later used in an international
proficiency test [42]. Indeed, in this exercise a consensus concentration was determined for the
ricin reference material based on different technological approaches available in independent expert
laboratories, indicating that the comparability of results was achieved [42].
The employed mass spectrometric analyses on tryptically digested materials revealed peptides
suitable for the identification and quantification of ricin isoforms and RCA120, i.e., peptides that are
proteotypic and detected at high intensity, and our results are in good agreement with previously
published data obtained with independent or commercial ricin preparations of different quality.
Recommendations are given as to which and how many peptides should be used to identify ricin D,
ricin E, and RCA120 unambiguously, and this information is potentially important in the course of
a forensic investigation.
As screening methods, two different ELISA methods were presented that preferentially detect
either ricin or RCA120 with only very little cross-reactivity between the two homologous analytes
down to the low pg/mL range, a concentration range that is relevant in the context of human ricin
intoxications (own unpublished data and [91]). While the ELISA-based methods are not suitable for
the unambiguous identification of ricin, they are most sensitive to detect ricin-containing samples
in the low pg/mL range which is usually not covered by spectrometric approaches. Also, the
applied mAb can effectively be used for immunoaffinity enrichment of ricin from complex matrices
followed by MS-based identification, combining and improving both technical approaches [62,92,93].
Generally, it has to be considered that antibody binding might be affected by the glycosylation of
ricin/RCA120, and interference could occur if the epitope recognized by an antibody contains or
is adjacent to a specific glycosylation site. However, when the ricin-ELISA described in this work
was used to detect ricin prepared from seven different cultivars of R. communis, no differences were
observed when equivalent amounts of toxin were tested (not shown).
In terms of function, a real-time cytotoxicity assay showed that the ricin reference material
prepared was approximately 300-fold more toxic than the corresponding RCA120 preparation, with
an IC50 value of 0.2 ng/mL for ricin and 60 ng/mL for RCA120. Exemplarily, previously published
IC50 values for ricin were determined at 8–60 ng/mL [29] and 0.14–0.4 ng/mL [45,94] and showed
that the precise IC50 value depends on different analytical parameters such as the cell line used
for the cytotoxicity assay, kinetics, purity, integrity, and post-translational modification of the toxin
used. Evaluation of toxicity in mice provided evidence for ricin being about 40–80-fold more toxic
than RCA120 [24], but comparative data on non-human primates are not available [95]. Overall,
comparison of the toxicity data is difficult as often no detailed information on the purity, lectin
composition, or the cultivar used is available. On the other hand, rodent and non-human primate
models have been valuable to delineate the pathophysiology of ricin toxicosis after systemic, oral, or
aerosol exposure or to analyze the efficacy of potential therapeutic agents [96].
In the context of protein function it would be interesting to extend the characterization further
to i) the identification of glycosylation patterns of the ricin isoforms isolated; ii) the precise
quantification of constituent ricin isoforms (D and E) in the mixture; and iii) the elucidation of
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secondary structures to highlight and follow the integrity of the molecules over time (e.g., by using
circular dichroism spectroscopy). Finally, it might be interesting to compare results obtained with
ricin reference material isolated from different cultivars of R. communis for additional validation
of identification and quantification methods. Especially glycosylation has been shown to be
important for protein function, and different glycosylation correlates with different toxicities [29]:
of three differently glycosylated ricin isoforms tested, the highest glycosylated form, containing
more hybrid/complex-type glycans with mannose as hexose units, has been shown to be most
toxic in different assay systems. Along the same line, the chemically deglycosylated ricin A
chain is about 1000-fold less toxic than the glycosylated ricin A chain in mice [97]. Furthermore,
N-glycosylation has been shown to promote the toxicity of the ricin A chain by promoting its
transport out of the endoplasmic reticulum [98]. Overall, there is convincing evidence showing
that glycosylation and especially the type of glycosylation of ricin does affect the function of the
molecule, a fact that is well known for a range of different proteins [99]. This is currently seen as
a counter-argument against the production of ricin reference material as a recombinant protein in
prokaryotic or eukaryotic expression systems (e.g., E. coli, P. pastoris or tobacco plants), which was
a successful approach for vaccine development [100]. To have the authentic glycosylation pattern or
post-translational modification, in general, on a ricin reference material purified from natural sources
seems to outweigh advantages of recombinant technologies such as the higher uniformity of proteins
produced. However, recombinant technologies or, in light of the cellular toxicity of ricin, cell-free
expression systems could be the way forward to produce stable isotope-labeled ricin that could be
used in the analytical workflow to determine sample preparation recovery rates or to document
the reproducibility of analytical procedures (e.g., enzymatic digestion efficiency for spectrometric
approaches). A prerequisite for using this approach, however, is that the pure (nonglycosylated)
isotopically labeled protein behaves the same way as the authentic protein.
Taken together, the experience acquired in this study can be exploited further in a next step
to develop certified ricin and RCA120 reference materials that would be available to international
expert laboratories. To place the activities in a larger context, decision-makers rely on correct and
reliable laboratory data in order to make appropriate decisions. Reliable detection, identification,
and quantification of ricin and RCA120 as well as their discrimination requires highly pure and
well-characterized reference materials. Due to the fact that ricin is classified as a C-weapon, this
issue could well be driven forward by internationally funded projects with technological expert
support from different nations and standardization bodies. Based on this, the cornerstones of the
next developments in the process of harmonization of analytical approaches would be highly specific
tools, thoroughly validated analytical procedures, recommended standard operating procedures,
well-trained personnel, and regular training in proficiency tests or ring trials.
Supplementary Materials: Supplementary materials can be accessed at: http://www.mdpi.com/2072-6651/7/
12/4856/s1.
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